Results 31 to 40 of about 180,460 (261)

Complying with the EU AI Act

open access: yes
The EU AI Act is the proposed EU legislation concerning AI systems. This paper identifies several categories of the AI Act. Based on this categorization, a questionnaire is developed that serves as a tool to offer insights by creating quantitative data.
Jacintha Walters   +3 more
openaire   +4 more sources

Implementation of the AI Act (EU) into the Polish legal system, its impact on this system and on selected strategic sectors [PDF]

open access: yesSafety & Fire Technology
Purpose: European Union regulations have the highest status among EU secondary legislation and are directly applicable in all Member States. Therefore, institutions, bodies, and various entities are required to apply the AI Act from the date of its entry
Monika Wyszomirska
doaj   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Análisis de la noción de las técnicas subliminales contenida en el artículo 5 (1) (a, b y c) del Reglamento de Inteligencia Artificial de la Unión Europea

open access: yesRevista Justicia y Derecho
El artículo examina la noción de técnicas subliminales, manipulativas o engañosas intencionadamente perjudiciales que influyen de forma significativa y sustancial en el comportamiento de personas físicas o grupos de personas prohibidas en el Artículo 5.1(
María Isabel Cornejo Plaza
doaj   +1 more source

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

open access: yesMolecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park   +6 more
wiley   +1 more source

Generative Ai, Copyright and the Ai Act

open access: yesComputer Law & Security Review
<div> This paper provides a critical analysis of the Artificial Intelligence (AI) Act's implications for the European Union (EU) copyright acquis, aiming to clarify the complex relationship between AI regulation and copyright law while identifying areas of legal ambiguity and gaps that may influence future policymaking.
openaire   +3 more sources

Epigenetic silencing of the liver‐specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation

open access: yesMolecular Oncology, EarlyView.
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang   +9 more
wiley   +1 more source

Analysis and perspectives on the AI Act: scope and impact assessment

open access: yesEuropean Journal of Privacy Law & Technologies
The article specifically examines the AI Act by analysing its objective, subjective and territorial scope. After an examination of the actors involved, dwelling on all the actors mentioned in the Regulation, the risk-based approach of AI systems and ...
Lucilla Gatt   +2 more
doaj   +1 more source

Single‐cell DNA methylation profiling: Technologies, computation, and applications in precision oncology

open access: yesMolecular Oncology, EarlyView.
Single‐cell DNA methylation (scDNAme) profiling maps epimutational clonal evolution, revealing mechanisms of malignancy and therapeutic resistance across diverse cancer types. By providing a high‐resolution landscape of intratumoral heterogeneity, these technologies empower precise patient stratification, guide the development of enhanced ...
Ik Soo Kim
wiley   +1 more source

Preparing for the AI Act

open access: yes, 2023
A briefing for ML practitioners on the potential impact of the EU's proposed AI Act on AI developers, the risk management apporach taken, the status of the current legislative and associated technical standards development processes and some the the relevant research to support practitioners from the PROTECTm ADAPT and EMPOWER research programmes.
openaire   +2 more sources

Home - About - Disclaimer - Privacy